stars 1 stars 2 stars 3

Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel tumor-directed oncolytic immunotherapies. We imagine a world where cancer is a curable disease.

View Top Employees from Replimune
Ticker REPL
Revenue $69.5 million
Funding $376 million
Employees 321 (289 on RocketReach)
Founded 2015
Address 500 Unicorn Park Dr Fl 3, Woburn, Massachusetts 01801, US
Phone (781) 222-9600
JavaScript, HTML, PHP +36 more (view full list)
Category Biotechnology Research, Pharmaceuticals, Health Care, Biotechnology, Healthcare, Medical, Therapeutics
Competitors Atara Biotherapeutics, Evelo Biosciences, Iovance Biotherapeutics Inc, Jounce Therapeutics, Inc., NextCure, Inc.
SIC 873, 87
NAICS 541, 541714, 5417, 54171, 54

Replimune Questions

The Replimune annual revenue was $69.5 million in 2023.

Pamela Esposito is the Chief Business Officer of Replimune.

289 people are employed at Replimune.

Replimune is based in Woburn, Massachusetts.

The NAICS codes for Replimune are [541, 541714, 5417, 54171, 54].

The SIC codes for Replimune are [873, 87].

Top Replimune Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users